Nigeria: Pfizer Moves to Check High Prevalence of Stroke in Nigeria

[Leadership] Pharmaceutical giant, Pfizer has relaunched Eliquis, an anticoagulant, to address the continued increase in the prevalence of stroke due to heart condition called atrial fibrillation in Nigeria which is a common cause of death in the adult population.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news